Trevi Therapeutics, Inc. TRVI Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s net change in cash?
- Trevi Therapeutics, Inc. (TRVI) reported net change in cash of $498K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s net change in cash changed year-over-year?
- Trevi Therapeutics, Inc.'s net change in cash increased by 103.4% year-over-year, from -$14.72M to $498K.
- What is the long-term trend for Trevi Therapeutics, Inc.'s net change in cash?
- Over 3 years (2022 to 2025), Trevi Therapeutics, Inc.'s net change in cash has grown at a -14.4% compound annual growth rate (CAGR), from -$24.24M to -$15.18M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.